Cluster analysis reveals abnormal hippocampal neurometabolic profiles in young people with mood disorders

Daniel F. Hermens*, Sharon L. Naismith, Kate M. Chitty, Rico S C Lee, Ashleigh Tickell, Shantel L. Duffy, Casey Paquola, Django White, Ian B. Hickie, Jim Lagopoulos

*Corresponding author for this work

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

While numerous studies have employed magnetic resonance spectroscopy (MRS) to determine in vivo neurometabolite levels associated with mood disorders the findings in both unipolar depression and bipolar disorder have been mixed. Data-driven studies may shed new light on this literature by identifying distinct subgroups of patients who may benefit from different treatment strategies. The objective of the present study was to utilize hierarchical cluster analysis in order to generate new hypotheses with respect to neurometabolic profiling of mood disorder. Participants were 165 young persons (18-30 yrs) with a mood disorder and 40 healthy controls. Neurometabolite levels were recorded via proton-MRS (1H MRS). The ratios (relative to creatine) of glutamate (GLU), N-acetyl aspartate (NAA) and myo-inositol (MI) measured within the hippocampus. Self-reported and clinician rated symptoms as well as cognition were also measured. The unipolar depression (N=90) and bipolar disorder (N=75) groups did not significantly differ (from each other or controls) in their levels of GLU, NAA or MI. Cluster analyses derived four subgroups of patients who were distinguished by all three metabolites. There was a pattern of positive association between NAA and GLU, whereby clusters were abnormally increased (clusters 1, 2) or normal (cluster 4) or abnormally decreased (cluster 3) in these neurometabolites. These findings suggest that there are neurometabolic abnormalities in subgroups of young people with mood disorder, which may occur despite diagnostic similarities. Such evidence highlights that the underlying neurobiology of mood disorder is complex and MRS may have unique utility in delineating underlying neurobiology and targeting treatment strategies.

Original languageEnglish
Pages (from-to)836-845
Number of pages10
JournalEuropean Neuropsychopharmacology
Volume25
Issue number6
DOIs
Publication statusPublished - 1 Jun 2015
Externally publishedYes

Keywords

  • Glutamate
  • Hippocampus
  • Mood disorders
  • Myo-inositol
  • N-acetyl aspartate
  • Proton magnetic resonance spectroscopy

Fingerprint Dive into the research topics of 'Cluster analysis reveals abnormal hippocampal neurometabolic profiles in young people with mood disorders'. Together they form a unique fingerprint.

Cite this